Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-04

Clinical Trial Update: Pharmacodynamic Effects of a Free-Fatty Acid Formulation of Omega-3 Pentaenoic Acid in Adults With Hypertriglyceridemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pharmacodynamic effects of a free-fatty acid formulation of omega-3 pentaenoic acid in adults with hypertriglyceridemia completed with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Matinas BioPharma Nanotechnologies, Inc. | Conditions: Hypertriglyceridemia | Phase 2 | Status: COMPLETED | Results posted: 2022-03-04